AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 55 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 27.25 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $49,000 | +8.9% | 83,869 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $45,000 | -40.0% | 83,869 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $75,000 | -7.4% | 83,869 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $81,000 | +5.2% | 83,869 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $77,000 | -27.4% | 83,869 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $106,000 | +5.0% | 83,869 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $101,000 | -29.4% | 83,869 | +1.9% | 0.00% | -25.0% |
| Q2 2015 | $143,000 | +11.7% | 82,292 | -6.7% | 0.00% | 0.0% |
| Q1 2015 | $128,000 | +73.0% | 88,219 | 0.0% | 0.00% | +33.3% |
| Q4 2014 | $74,000 | -32.7% | 88,219 | -11.2% | 0.00% | -25.0% |
| Q3 2014 | $110,000 | -43.6% | 99,319 | -6.9% | 0.00% | -42.9% |
| Q2 2014 | $195,000 | +21.9% | 106,701 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $160,000 | -20.0% | 106,701 | -2.2% | 0.01% | -30.0% |
| Q4 2013 | $200,000 | -28.1% | 109,101 | -2.0% | 0.01% | -52.4% |
| Q2 2013 | $278,000 | – | 111,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,590,673 | $1,399,000 | 1.00% |
| Deer VI & Co. LLC | 675,242 | $365,000 | 0.28% |
| Sarissa Capital Management LP | 1,700,000 | $917,000 | 0.25% |
| NEA Management Company, LLC | 10,362,694 | $5,596,000 | 0.22% |
| Perceptive Advisors | 3,108,808 | $1,678,000 | 0.12% |
| Cormorant Asset Management, LP | 1,087,715 | $587,000 | 0.08% |
| 683 Capital Management, LLC | 1,000,000 | $540,000 | 0.04% |
| Spark Investment Management LLC | 95,800 | $51,000 | 0.00% |
| Elgethun Capital Management | 10,000 | $5,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 14,738 | $8,000 | 0.00% |